Form 4 for RMD ResMed|
Accepted 2026-09-04 06:30:09 ET · period of report 2026-09-02 · accession 0000943819-26-000050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-04 06:30 | 2026-09-02 | RMD | FARRELL PETER C | Dir | S - Sale | $234.73 | -970 | 51.8K | -2% | -$227.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2026-09-02 | S | D | 970 | $234.73 | 51,803 | D | — | — | (F1) The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025. |